ODT stock forecast
Our latest prediction for Odonate Therapeutics, Inc.'s stock price was made on the June 26, 2019 when the stock price was at 31.76$.
In the short term (2weeks), ODT's stock price should outperform the market by 3.69%. During that period the price should oscillate between -9.16% and +13.01%.
In the medium term (3months), ODT's stock price should outperform the market by 2.57%. During that period the price should oscillate between -19.93% and +30.16%.Get email alerts
Create a solid portfolio with ODT
About Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -4.11$ per share.
The book value per share is 6.41$
Three months stock forecastJune 26, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|